Outcomes of elderly de novo acute myeloid leukemia treated by a risk‐adapted approach based on age, comorbidity, and performance status-Reference-Cited by-同舟云学术

Outcomes of elderly de novo acute myeloid leukemia treated by a risk‐adapted approach based on age, comorbidity, and performance status

Published:2013-09-12 Issue:12 Volume:88 Page:1074-1081
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Yoon Jae‐Ho¹,Cho Byung‐Sik¹,Kim Hee‐Je¹,Kim Jung‐Ho¹,Shin Seung‐Hwan¹,Yahng Seung‐Ah¹,Lee Sung‐Eun¹,Eom Ki‐Seong¹,Kim Yoo‐Jin¹,Lee Seok¹,Min Chang‐Ki¹,Cho Seok‐Goo¹,Kim Dong‐Wook¹,Lee Jong‐Wook¹,Min Woo‐Sung¹,Park Chong‐Won¹

Affiliation:

1. Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's hospitalThe Catholic University of KoreaSeoul Korea

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.23576

Reference41 articles.

1. Therapeutic Advances in Acute Myeloid Leukemia

2. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

3. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461